| Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-child HIV Transmission in Africa (NCT01088516) | University of Zambia | 2008-12-01 |
| An HIV Intervention for Black Men at Risk - The Enhanced Sexual Health Intervention for Men (ES-HIM) (NCT01641146) | University of California, Los Angeles | 2008-12-01 |
| Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection (NCT00789009) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-11-20 |
| Analysis of HIV-1 Replication During Antiretroviral Therapy (NCT00767312) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-11-17 |
| Vaccination of HIV-1 Infected Patients With Dendritic Cells in Addition to Antiretroviral Treatment - (DALIA Trial) (NCT00796770) | Baylor Research Institute | 2008-11-01 |
| Impact of Different Contraceptives on the Immune System of HIV Infected Women in Zambia (NCT00807625) | University of Alabama at Birmingham | 2008-11-01 |
| Effects of Motivational Interviewing on Risky Injecting Practices Among Injecting Drug Users (IDUs) (NCT00794391) | Université de Sherbrooke | 2008-11-01 |
| Phase IIB Pilot of Atazanavir + Raltegravir (NCT00768989) | Bristol-Myers Squibb | 2008-11-01 |
| Empowerment Intervention for Young Women - Phase I (NCT00891358) | University of North Carolina, Chapel Hill | 2008-11-01 |
| A Pilot,Raltegravir Versus NRTIs as a Backbone Switched From a Stable Boosted PI Regimen (NCT00749580) | University of South Florida | 2008-11-01 |
| Russian Labor Migrant HIV Prevention Trial (NCT01177995) | Medical College of Wisconsin | 2008-10-01 |
| Artemether/Lumefantrine and Nevirapine Interaction Study in HIV-infected Adults (NCT00790881) | University of Cape Town | 2008-10-01 |
| NNRTI/PI Toxicity Switch to Darunavir Study (NCT00765154) | St Stephens Aids Trust | 2008-10-01 |
| Behavioral Intervention to Reduce Sexual and Injection Risks Among Female Sex Workers Who Also Inject Drugs in Mexico (NCT00840658) | Steffanie Strathdee | 2008-10-01 |
| Influenza Vaccine in HIV (NCT00764998) | Ottawa Hospital Research Institute | 2008-10-01 |
| TMC278-TiDP6-C121: Drug-drug Interaction Trial to Investigate the Potential Interaction Between TMC278 25 mg Daily and Methadone, at Steady State. (NCT00744770) | Tibotec Pharmaceuticals, Ireland | 2008-10-01 |
| Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-infected Patients That Have Never Received Treatment (NCT00757783) | Tibotec, Inc | 2008-10-01 |
| Women-Focused HIV Prevention in the Western Cape (NCT00729391) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2008-09-26 |
| A Study to Determine the Safety and Efficacy of Once Daily Raltegravir Compared to Twice Daily Raltegravir (MK-0518-071) (NCT00745823) | Merck Sharp & Dohme LLC | 2008-09-01 |
| Cognitive and Psychosocial Benefits of MISC Training for Ugandan Children (NCT00889395) | Makerere University | 2008-09-01 |
| Therapy Targeting Depression and HIV Treatment Adherence (The TRIAD Study) (NCT00951028) | Massachusetts General Hospital | 2008-09-01 |
| Transitions: Linkages From Jail To Community (NCT00841711) | Yale University | 2008-09-01 |
| Alcohol, Suicide and HIV Prevention for Teens in Mental Health Treatment (NCT02228044) | George Mason University | 2008-09-01 |
| TMC125-TiDP2-C197: A Phase I Trial to Investigate the Pharmacokinetic Interaction Between Lopinavir/Ritonavir and TMC125 Both at Steady-state in Healthy Volunteers. (NCT00767117) | Tibotec Pharmaceuticals, Ireland | 2008-09-01 |
| TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects. (NCT00740389) | Tibotec Pharmaceuticals, Ireland | 2008-09-01 |
| HSV Oral Reactivation in Children (NCT01878279) | Dartmouth-Hitchcock Medical Center | 2008-09-01 |
| Online Social Networking for HIV Prevention (NCT00725959) | Colorado School of Public Health | 2008-09-01 |
| A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects (NCT00743470) | Abbott | 2008-08-01 |
| Dose-Response Study of Ibalizumab (Monoclonal Antibody) Plus Optimized Background Regimen in Patients With HIV-1 (NCT00784147) | TaiMed Biologics Inc. | 2008-08-01 |
| TMC114-TiDP3-C181: Study to Assess the Pharmacokinetics of Darunavir (DRV) With Different Doses of Ritonavir in Healthy Volunteers. (NCT00744887) | Tibotec Pharmaceuticals, Ireland | 2008-08-01 |
| A Pilot Study to Characterize the Pharmacokinetics of Raltegravir in the Cervicovaginal Fluids of HIV-infected Women (NCT00774683) | Kristine Patterson, MD | 2008-08-01 |
| Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C Infections (NCT00742326) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-08-01 |
| Video-based Counseling & Rapid HIV Testing for Teens (NCT00836550) | North Bronx Healthcare Network | 2008-08-01 |
| Safety Study of the HemoModulator System for the Treatment of Patients With Human Immunodeficiency Virus (HIV) (NCT00858923) | Energex Systems, Inc. | 2008-07-01 |
| Assess the Downregulation of HIV-1 When Raltegravir is Added to a Virologically Suppressed HAART Regimen (NCT00738569) | National Jewish Health | 2008-07-01 |
| Measurement of Adherence to ART in HIV-Infected Children in Uganda (The CHARTA Study) (NCT00868257) | Massachusetts General Hospital | 2008-07-01 |
| Brain Deficits in HIV/HCV Coinfected People Before and After Anti-HCV Therapy (NCT00747539) | University of California, Los Angeles | 2008-07-01 |
| TMC278-TiDP6-C136: Effect of TMC278 on Ethinylestradiol and Norethindrone in Healthy Women. (NCT00739622) | Tibotec Pharmaceuticals, Ireland | 2008-07-01 |
| Raltegravir and Ezetimibe PK Study (NCT00772551) | St Stephens Aids Trust | 2008-06-01 |
| Evaluating Post-test HIV Counseling Videos for Teens (NCT00851539) | North Bronx Healthcare Network | 2008-06-01 |
| VX-950-TiDP24-C124: A Phase I Trial to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-state. (NCT00775125) | Tibotec BVBA | 2008-06-01 |
| Pilot Study Switching Individuals Receiving EFV With Continuing Central Nervous System Toxicity to TMC125 (NCT00792324) | St Stephens Aids Trust | 2008-06-01 |
| TMC278-TiDP6-C130: Pharmacokinetics, Safety and Tolerability of TMC278 in Subjects With Mildly or Moderately Impaired Hepatic Function. (NCT00736905) | Tibotec Pharmaceuticals, Ireland | 2008-06-01 |
| Abacavir Pharmacokinetic Study in the Absence/Presence of Darunavir/Ritonavir or Raltegravir in HIV-infected Subjects (NCT00765271) | St Stephens Aids Trust | 2008-05-01 |
| Preference of Genetic Polymorphism and Pharmacokinetics (NCT01658371) | Chinese University of Hong Kong | 2008-05-01 |
| Pharmacokinetic and Pharmacodynamic Study of TH9507, a Growth Hormone-Releasing Factor Analog, in HIV Positive Patients (NCT02012556) | Theratechnologies | 2008-05-01 |
| An Educational and Supportive Counseling Program for Increasing Antiretroviral Use and Adherence in People With HIV (NCT00611429) | University of California, San Francisco | 2008-05-01 |
| Client-Centered Counseling During Routine/Opt-Out HIV-Testing in Uganda (NCT02438930) | Susan M. Kiene | 2008-05-01 |
| HIV Prevention for Injecting Drug Users in Kazakhstan (NCT01690442) | Columbia University | 2008-05-01 |
| Relapse Prevention to Reduce HIV Among Women Prisoners (NCT00763958) | University of Alabama at Birmingham | 2008-05-01 |
| Efficacy of HIV Post-Test Support for ANC in South Africa (NCT01683461) | University of North Carolina, Chapel Hill | 2008-05-01 |
| Efficacy of Influenza Vaccine in HIV Infected Adults (NCT00757900) | University of Witwatersrand, South Africa | 2008-04-01 |
| Linkage to Care - Part I (NCT00703040) | University of North Carolina, Chapel Hill | 2008-03-01 |
| Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment (NCT00737724) | Instituto Nacional de Enfermedades Respiratorias | 2008-03-01 |
| TDM of Generic Lopinavir/Ritonavir 200/50 mg (NCT00802334) | The HIV Netherlands Australia Thailand Research Collaboration | 2008-01-01 |
| A Trial Examining the Efficacy of Escitalopram Oxalate Upon Depressive Symptoms and Fatigue in HIV Seropositive Women (NCT01797380) | Duke University | 2008-01-01 |
| Positive Lifestyles Using Safety (NCT00836290) | Yale University | 2008-01-01 |
| Prevention for Positives: An RCT Among Vietnamese HIV-positive IDU (NCT01689545) | Johns Hopkins Bloomberg School of Public Health | 2007-12-01 |
| Progress Adult Study (NCT01328275) | The HIV Netherlands Australia Thailand Research Collaboration | 2007-12-01 |
| Conjugate And Polysaccharide Vaccines Compared With Polysaccharide Vaccine In Hiv-Infected Adults (NCT00999739) | Hospital Universitari Son Dureta | 2007-12-01 |
| Outcome at 5 Years of Early Treated HIV Infected Infants in the PEDIACAM Project (NCT02043418) | ANRS, Emerging Infectious Diseases | 2007-11-01 |
| The SASA! Study: An Evaluation of a Community Intervention to Address Gender-based Violence and Reduce HIV/AIDS Risk in Uganda (NCT00790959) | London School of Hygiene and Tropical Medicine | 2007-10-01 |
| Assisting HIV-infected Mothers in Disclosing Their Serostatus to Their Children (NCT00429546) | University of California, Los Angeles | 2007-09-01 |
| Neighborhood Alcohol & HIV Prevention in South African Townships (Philani) (NCT00996528) | University of California, Los Angeles | 2007-09-01 |
| Neighborhoods, Networks, Depression, and HIV Risk (NCT01380613) | Johns Hopkins Bloomberg School of Public Health | 2007-09-01 |
| Schooling, Income, and HIV Risk in Malawi (NCT01333826) | George Washington University | 2007-09-01 |
| Men of African American Legacy Empowering Self (NCT01492530) | Charles Drew University of Medicine and Science | 2007-08-01 |
| Thai Prophylactic HIV Vaccine Phase I Study (NCT00333424) | Kirby Institute | 2007-08-01 |
| HIV Prevention Among Vulnerable Male Youth (NCT01771237) | Ann & Robert H Lurie Children's Hospital of Chicago | 2007-07-01 |
| Pregnant Women's CoOp (NCT00722670) | RTI International | 2007-06-01 |
| A Phase 2 Study Of PF-00232798 In HIV Positive Patients (NCT00495677) | Pfizer | 2007-06-01 |
| Cell Phone Intervention to Support Antiretroviral Therapy (ART) Adherence in Kenya (NCT00830622) | University of Manitoba | 2007-05-01 |
| Effects of CYP2B6 Genetic Polymorphisms on Efavirenz Pharmacokinetics (NCT00668395) | Indiana University | 2007-05-01 |
| Enfuvirtide/Current Protease Inhibitor Switch to PREZISTA (Darunavir)/Ritonavir + TMC125 in HIV Patients With Enfuvirtide Side Effects. (NCT00460746) | Tibotec, Inc | 2007-05-01 |
| Case Management Alternatives for African American Women at High Risk for HIV (NCT00780260) | Nova Southeastern University | 2007-05-01 |
| Ritonavir-boosted Lopinavir Monotherapy (NCT01002898) | Bamrasnaradura Infectious Diseases Institute | 2007-04-01 |
| EuroSIDA As An External Comparator To MOTIVATE Trials (NCT01329783) | ViiV Healthcare | 2007-04-01 |
| Analysis of Data Collected From Individuals Administered Neurobehavioral Assessments (NCT01445314) | National Cancer Institute (NCI) | 2007-03-23 |
| Accuracy of Hemoglobin A1C to Predict Glycemia in HIV (NCT00433628) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-02-07 |
| Intervention for Newly Diagnosed Youth With HIV (NCT00510237) | University of North Carolina, Chapel Hill | 2007-02-01 |
| The Effect of Pregnancy on the Pharmacokinetics of the Kaletra Tablet (NCT00766818) | University of North Carolina, Chapel Hill | 2007-01-01 |
| Development of a Methamphetamine Early Intervention (NCT01174654) | University of Washington | 2006-12-01 |
| HIV Viral Load Monitoring in Resource-Poor Settings (NCT00929604) | University of Alabama at Birmingham | 2006-12-01 |
| HIV Testing & Womens Attitudes on HIV Vaccine Trials (NCT00771537) | Indiana University | 2006-11-01 |
| GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men. (NCT00381303) | Tibotec, Inc | 2006-11-01 |
| Randomized Placebo-Controlled Trial of Atorvastatin in HIV-Positive Patients Not on Antiretroviral Therapy (NCT00367458) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-10-18 |
| Addressing Young Men's Substance Use and HIV Risk (NCT00325702) | Public Health Management Corporation | 2006-10-01 |
| Testing a Community-Friendly Risk Reduction Intervention for Injection Drug Users (NCT01741350) | University of Connecticut | 2006-09-01 |
| Genetics and HIV-1 Protease Inhibitors (NCT01388543) | University of Colorado, Denver | 2006-09-01 |
| Modification of Doses of Efavirenz According to Its Blood Concentration in HIV Patients (NCT00299091) | Germans Trias i Pujol Hospital | 2006-09-01 |
| Switch From Combivir or Trizivir to Truvada - Mitochondrial Effects (NCT00960622) | St. Luke's-Roosevelt Hospital Center | 2006-08-01 |
| Study of Impacts of Food Supplementation on Malnourished HIV-Infected Adults in Kenya (NCT00838292) | Academy for Educational Development | 2006-08-01 |
| Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV Co-infected Patients (NCT00358696) | University of British Columbia | 2006-07-01 |
| Risk Reduction Intervention for Vulnerable Young Adult Males (NCT01118416) | Hunter College of City University of New York | 2006-06-01 |
| Evaluation of Effectiveness of Pharmaceutical Care on the Adherence of HIV-Positive Patients to Antiretroviral Therapy (NCT00959361) | Hospital de Clinicas de Porto Alegre | 2006-06-01 |
| Sildenafil to Treat HIV-Associated Pulmonary Hypertension (NCT00327080) | National Heart, Lung, and Blood Institute (NHLBI) | 2006-05-12 |
| Alveolar Macrophage Proteomics in HIV-associated Emphysema (NCT00823927) | Philip Diaz | 2006-04-21 |
| Nutrition, Diabetes and Pulmonary TB/HIV (NCT00311298) | University of Copenhagen | 2006-04-01 |
| A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination (NCT00335270) | Duke University | 2006-03-01 |
| Validation of System for Monitoring the Effectiveness of Antiretroviral Therapy in HIV-Infected Patients in Africa (NCT00341393) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-02-16 |